FOLH1 and neoplasm: In these 6 patients, verification was based on an MRI scan (bone marrow infiltration, n = 1), on decreasing PSA levels after salvage radiotherapy of the prostate fossa or the pelvic lymph nodes (n = 3), or a follow-up PSMA PET/CT scan exhibiting tumor progression (n = 2).